Early patisiran initiation safe, effective in hereditary transthyretin-mediated amyloidosis with polyneuropathy: JAMA Dr. Shravani Dali15 Jan 2025 9:00 PM ISTIn the longest study of an RNAi therapeutic for any disease, patisiran treatment demonstrated modest improvements in patients with hereditary...
Rare Disease Show Episode 22: Understanding Amyloidosis with Dr Sanju Daniel John Dr. Nandita Mohan31 Dec 2024 8:45 AM IST Medical Dialogues presents a rare disease series, delving into the realm of uncommon medical conditions. Rare diseases are medical conditions...
Vutrisiran offers new lifeline to patients with transthyretin amyloidosis with cardiomyopathy: Study Dr. Kamal Kant Kohli10 Sept 2024 10:00 PM ISTVutrisiran significantly improved mortality, cardiovascular events and markers of disease progression in patients with transthyretin amyloidosis with...
Johnson and Johnson Gets CDSCO Panel Nod For Additional Indication of Daratumumab to Treat Light chain AL amyloidosis Dr. Divya Colin25 May 2024 6:00 PM ISTNew Delhi: Granting local clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
AstraZeneca Wainua gets USFDA nod for adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis Ruchika Sharma24 Dec 2023 2:45 PM ISTUS: AstraZeneca and Ionis' Wainua (eplontersen) has been approved in the US for the treatment of the polyneuropathy of hereditary...
Patisiran Offers New Hope for Patients Battling ATTR Cardiac Amyloidosis Dr.Niharika Harsha B31 Oct 2023 8:30 PM ISTIn a pivotal development, a groundbreaking phase 3 clinical trial has revealed positive outcomes for patients grappling with transthyretin...
Early tafamidis treatment helps improve survival in patients with transthyretin amyloid cardiomyopathy Dr. Kamal Kant Kohli29 July 2023 10:00 AM ISTUK: In a recent study published in the European Journal of Heart Failure, the researchers have stressed the importance of timely treatment with...
Transthyretin cardiac amyloidosis can be reversed, opening new possibilities for more effective treatment options Dr. Kamal Kant Kohli9 Jun 2023 8:00 PM ISTUK: A new study, published as a letter in The New England Journal of Medicine, reports on three men, aged 68, 76 and 82, who were diagnosed with...
Amrita Hospital Kochi launches India's First Amyloid Centre Kajal Rajput14 May 2023 4:30 PM ISTKochi: Amrita Hospital, Kochi, a premier hospital in South Asia, has launched India's first Center of Excellence for the evaluation and treatment of...
Amyloidosis of Femoral Neck: An Unusual Cause of Pathologic Fracture Dr Supreeth D R30 Sept 2022 7:30 PM ISTThe deposition of amyloid within human tissue can be detrimental to the proper functioning of multiple organ systems. While the infiltration of the...
Advanced MRI benefits patients with heart stiffening disease Dr. Kamal Kant Kohli2 Aug 2022 10:00 AM ISTAn advanced form of cardiac MRI, developed by academics at UCL in collaboration with the Royal Free Hospital, has for the first-time enabled...
Dermoscopy of primary cutaneous amyloidosis: A retrospective analysis Dr Manoj Kumar Nayak27 Aug 2021 9:00 AM ISTDermoscopy of primary cutaneous amyloidosis : AJD study Primary cutaneous amyloidosis (PCA) are a group of benign dermatoses characterized...
